• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Predicting the number of patients on dialysis and renal transplant recipients in Denmark].

作者信息

Vestergaard P, Løkkegaard H

机构信息

Afdeling 900, Arhus Amtssygehus, Arhus Universitetshospital.

出版信息

Ugeskr Laeger. 1998 Jul 27;160(31):4520-3.

PMID:9700307
Abstract

A Markov model was applied in three ways: 1) a deterministic model with fixed rates, 2) a stochastic model using simulated varying rates and 3) a deterministic model with increasing rates. With present rates an increase in the prevalence of renal transplant recipients < 60 years (from 1003 in 1995 to about 1465 in 2006) and the prevalence of haemodialysis patients less than or equal to 60 years (from 456 in 1995 to about 903 in 2006) was predicted. The prevalence in other treatment modalities would change less. The overall prevalence proportion would increase from 539 patients/mio. inhabitants in 1995 to about 777/mio. in 2006. Observed and expected numbers with the stochastic model in 1996 were: haemodialysis: 1053 (1074 +/- 41, 2p = 0.61), peritoneal dialysis: 456 (480 +/- 22, 2p = 0.28) and renal transplant recipients: 1232 (1266 +/- 14, 2p = 0.015). The deterministic model with increasing rates predicted an overall prevalence of 1162 patients/mio. in 2006.

摘要

相似文献

1
[Predicting the number of patients on dialysis and renal transplant recipients in Denmark].
Ugeskr Laeger. 1998 Jul 27;160(31):4520-3.
2
[Active treatment of uremia in the study county of Vejle. Epidemiology 1979-1994 and future perspectives].
Ugeskr Laeger. 1996 Jun 24;158(26):3759-63.
3
[Report by the Health Council on dialysis and kidney transplantation].卫生委员会关于透析和肾脏移植的报告
Ned Tijdschr Geneeskd. 1993 Apr 10;137(15):748-9.
4
End-stage renal disease and its treatment in Latin America in the twenty-first century.21世纪拉丁美洲的终末期肾病及其治疗
Ren Fail. 2006;28(8):631-7. doi: 10.1080/08860220600925693.
5
ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.千禧年末澳大利亚和新西兰的终末期肾病:来自澳新透析与移植登记处的报告
Am J Kidney Dis. 2002 Dec;40(6):1122-31. doi: 10.1053/ajkd.2002.36943.
6
End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions.终末期肾病:问题的严重程度、未来趋势的预后及可能的解决方案。
Kidney Int Suppl. 1995 Aug;50:S3-6.
7
Slovenian renal replacement therapy registry: excerpts from the 2006 annual report.斯洛文尼亚肾脏替代治疗登记处:2006年年度报告摘录。
Ther Apher Dial. 2009 Aug;13(4):258-63. doi: 10.1111/j.1744-9987.2009.00739.x.
8
[Epidemiologic aspects of terminal chronic kidney failure and its therapeutic modalities].[终末期慢性肾衰竭的流行病学特征及其治疗方式]
Prog Urol. 1996 Oct;6(5):683-5.
9
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience].[意大利透析与移植登记处:1996 - 2001年经验]
G Ital Nefrol. 2004 Nov-Dec;21(6):561-7.
10
Demographic and organizational developments of maintenance dialysis therapies--past, present, outlook into the future.维持性透析治疗的人口统计学和组织发展——过去、现在、未来展望
J Nephrol. 1999 Jul-Aug;12 Suppl 2:S47-52.